Key Record Dates
ClinicalTrials.gov Identifier: | NCT05907954 |
---|---|
Brief Title: | (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma |
First Submitted : | June 6, 2023 |
First Submitted that Met QC Criteria : | June 14, 2023 |
First Posted : | June 18, 2023 |
Last Update Submitted that Met QC Criteria : | March 26, 2024 |
Last Update Posted : | March 28, 2024 |